PSI-Immune
Phase 2 Recruiting
880 enrolled
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
76 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
450 enrolled
Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments
Phase 1/2 Recruiting
350 enrolled
PAROLA
Phase 3 Recruiting
510 enrolled
INDIGO
Phase NA Recruiting
11,200 enrolled
A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
949 enrolled
TroFuse-020
Phase 3 Recruiting
686 enrolled
TroFuse-036
Phase 3 Recruiting
1,023 enrolled
A Study to Evaluate the Safety, Tolerability, Preliminary Efficacy of KRC-01
Phase 1 Recruiting
70 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 Recruiting
1,006 enrolled
STEALTH-001
Phase 1 Recruiting
60 enrolled
A Study of SHR-A2102 Versus Investigator's Choice of Chemotherapy in Patients With Platinum-based Chemotherapy and PD-(L)1 Inhibitor Treatment Failed Recurrent or Metastatic Cervical Cancer
Phase 3 Recruiting
398 enrolled
HPV-Vac-S
Recruiting
5,500 enrolled
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN Trials
Phase NA Recruiting
400 enrolled
SHIP-A-S01
Phase NA Recruiting
750 enrolled
Pap
Phase NA Recruiting
250 enrolled
DP-04
Recruiting
100 enrolled
RAD301
Phase 1 Recruiting
9 enrolled
Strategies to Close the Gap From Cervical Cancer Diagnosis to Treatment in Botswana
Phase NA Recruiting
610 enrolled
SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer
Phase 2 Recruiting
89 enrolled
AppDate-You
Phase NA Recruiting
3,000 enrolled
MOTTO
Phase NA Recruiting
524 enrolled
BetaBart
Phase 1/2 Recruiting
61 enrolled
HypoRTCx-UG
Phase 2 Recruiting
278 enrolled
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
Phase 2 Recruiting
50 enrolled
HART
Recruiting
120 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
eVOLVE-02
Phase 2 Recruiting
257 enrolled
KOPRETINA
Phase NA Recruiting
15,000 enrolled
Reiki-Brachy
Phase 2 Recruiting
68 enrolled
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Phase 1 Recruiting
280 enrolled
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Phase 1/2 Recruiting
205 enrolled
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Phase 1 Recruiting
40 enrolled
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 Recruiting
48 enrolled
Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer
Phase NA Recruiting
558 enrolled
Keynote B59
Phase 1/2 Recruiting
317 enrolled
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
233 enrolled
PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer
Phase 2/3 Recruiting
120 enrolled
PNeoVCA
Phase 1/2 Recruiting
132 enrolled
PROPS GYN
Phase 2 Recruiting
25 enrolled
ELEPHAS-04
Recruiting
324 enrolled
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
Phase 4 Recruiting
100 enrolled
Talazoparib and Radiation Therapy in Treating Patients With Locally Recurrent Gynecologic Cancers
Phase 1 Recruiting
24 enrolled
POC
Phase NA Recruiting
5,000 enrolled
AIM-C1
Phase NA Recruiting
40 enrolled
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Phase 1 Recruiting
110 enrolled
A Study of YL202 in Patients With Advanced Solid Tumors
Phase 2 Recruiting
100 enrolled
Cervical Cancer Detection Using Optical Spectroscopy
Phase NA Recruiting
350 enrolled